Back

Questions and answers

2 September 2019 (13:35 - 13:45)
Organised by:
Congress Presentation Part of: Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing? Diabetes and the Heart ESC Premium Access ESC Congress 2019

6 More presentations in this session

Presentation thumbnail
Welcome and opening remarks
Professor D. McGuire (Dallas, US)
Slides Video
Presentation thumbnail
What is the role for SGLT2is for patients with heart failure? A cardiologist’s view
Professor G. Filippatos (Athens, GR)
Slides Video
Presentation thumbnail
SGLT2 Inhibitors - Diabetes or renal drugs?
Professor P. Groop (Helsinki, FI)
Slides Video
Presentation thumbnail
Ertugliflozin and the VERTIS program – What have we learned to date?
Professor L. Leiter (Toronto, CA)
Slides Video
Presentation thumbnail
Bringing forward the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease - A roundtable dscussion
Professor P. Groop (Helsinki, FI) Professor D. McGuire (Dallas, US) Professor G. Filippatos (Athens, GR) Professor L. Leiter (Toronto, CA)

Access the full session

Session thumbnail
Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?

The Event

Event poster

ESC Congress 2019

2 September 2019 13:35 CET
You may be interested in
thumbnail
Congress Presentation
Summary.
29 August 2022
thumbnail
Congress Session
Multidisciplinary approach in heart failure clinic
19 May 2025
thumbnail
Congress Presentation
Roundtable discussion - Q&A
31 August 2025
thumbnail
Webinar
Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?
21 July 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources